국가 임상시험 허브 플랫폼

연구자 정보

기본정보

연구자명: Ae-Young Her (Heo)

국가: South Korea

소속기관: Kangwon National University

전문분야: Cardiology

임상시험 수행내역

임상시험 수행 경력: 10 년

다기관 임상시험 수행여부: Yes

IND 제출 이력(수): 0 건

관련 논문/출판물(수): 71 건

수행 임상시험 정보 세부

총 16 건

Trial Title: Ticagrelor Monotherapy After 3 Months in the Patients Treated with New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Therapy Area: Cardiovascular

Indication(s): Unstable Angina

Investigator’s Role: Co-Author

Trial Phase: Phase IV

Trial Status: Completed

Trial Title: Ticagrelor Monotherapy After 3 Months in the Patients Treated with New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Therapy Area: Cardiovascular

Indication(s): Coronary Artery Disease (CAD) (Ischemic Heart Disease)

Investigator’s Role: Co-Author

Trial Phase: Phase IV

Trial Status: Completed

Trial Title: Ticagrelor Monotherapy After 3 Months in the Patients Treated with New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Therapy Area: Cardiovascular

Indication(s): Thrombosis

Investigator’s Role: Co-Author

Trial Phase: Phase IV

Trial Status: Completed

Trial Title: Ticagrelor Monotherapy After 3 Months in the Patients Treated with New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Therapy Area: Cardiovascular

Indication(s): Stroke

Investigator’s Role: Co-Author

Trial Phase: Phase IV

Trial Status: Completed

Trial Title: Ticagrelor Monotherapy After 3 Months in the Patients Treated with New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Therapy Area: Cardiovascular

Indication(s): Myocardial Infarction

Investigator’s Role: Co-Author

Trial Phase: Phase IV

Trial Status: Completed

Trial Title: Ticagrelor Monotherapy After 3 Months in the Patients Treated with New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Therapy Area: Cardiovascular

Indication(s): Acute Coronary Syndrome

Investigator’s Role: Co-Author

Trial Phase: Phase IV

Trial Status: Completed

Trial Title: Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients with Large Coronary Artery Disease(REVERSE)

Therapy Area: Cardiovascular

Indication(s): Coronary Artery Disease (CAD) (Ischemic Heart Disease)

Investigator’s Role: Contact Person; Principal Investigator

Trial Phase: Phase III

Trial Status: Ongoing, recruiting

Trial Title: Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients with Large Coronary Artery Disease(REVERSE)

Therapy Area: Cardiovascular

Indication(s): Coronary Stenosis

Investigator’s Role: Contact Person; Principal Investigator

Trial Phase: Phase III

Trial Status: Ongoing, recruiting

Trial Title: Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients with Large Coronary Artery Disease(REVERSE)

Therapy Area: Cardiovascular

Indication(s): Acute Coronary Syndrome

Investigator’s Role: Contact Person; Principal Investigator

Trial Phase: Phase III

Trial Status: Ongoing, recruiting

Trial Title: Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients with Large Coronary Artery Disease(REVERSE)

Therapy Area: Cardiovascular

Indication(s): Myocardial Ischemia

Investigator’s Role: Contact Person; Principal Investigator

Trial Phase: Phase III

Trial Status: Ongoing, recruiting

Trial Title: Evaluation of Effectiveness and Safety of Biomime Stent in the Korean Patients with Acute Coronary Syndrome; Multicenter, Prospective, Observational Clinical Trial

Therapy Area: Cardiovascular

Indication(s): Angina (Angina Pectoris)

Investigator’s Role: Co-Author

Trial Phase: Phase IV

Trial Status: Completed

Trial Title: Evaluation of Effectiveness and Safety of Biomime Stent in the Korean Patients with Acute Coronary Syndrome; Multicenter, Prospective, Observational Clinical Trial

Therapy Area: Cardiovascular

Indication(s): Myocardial Infarction

Investigator’s Role: Co-Author

Trial Phase: Phase IV

Trial Status: Completed

Trial Title: Evaluation of Effectiveness and Safety of Biomime Stent in the Korean Patients with Acute Coronary Syndrome; Multicenter, Prospective, Observational Clinical Trial

Therapy Area: Cardiovascular

Indication(s): Acute Coronary Syndrome

Investigator’s Role: Co-Author

Trial Phase: Phase IV

Trial Status: Completed

Trial Title: A Prospective, Multicenter, Randomized Clinical Study Comparing the Effectiveness and Safety of Post-stabilization Prasugrel-only Antiplatelet Therapy and Dual Antiplatelet Therapy with Clopidogrel in Patients with Acute Coronary Syndrome Who Underwent Complex-high-risk Coronary Intervention

Therapy Area: Cardiovascular

Indication(s): Unstable Angina

Investigator’s Role: Principal Investigator

Trial Phase: Phase III

Trial Status: Ongoing, recruiting

Trial Title: A Prospective, Multicenter, Randomized Clinical Study Comparing the Effectiveness and Safety of Post-stabilization Prasugrel-only Antiplatelet Therapy and Dual Antiplatelet Therapy with Clopidogrel in Patients with Acute Coronary Syndrome Who Underwent Complex-high-risk Coronary Intervention

Therapy Area: Cardiovascular

Indication(s): Acute Coronary Syndrome

Investigator’s Role: Principal Investigator

Trial Phase: Phase III

Trial Status: Ongoing, recruiting

Trial Title: A Prospective, Multicenter, Randomized Clinical Study Comparing the Effectiveness and Safety of Post-stabilization Prasugrel-only Antiplatelet Therapy and Dual Antiplatelet Therapy with Clopidogrel in Patients with Acute Coronary Syndrome Who Underwent Complex-high-risk Coronary Intervention

Therapy Area: Cardiovascular

Indication(s): Percutaneous Coronary Intervention

Investigator’s Role: Principal Investigator

Trial Phase: Phase III

Trial Status: Ongoing, recruiting

목록보기